Silver Spring, Md. - The FDA Dermatologic and Ophthalmic AdvisoryCommittee, by an 8-2 vote, on May 23 recommended approval of alefacept,a systemic drug for the treatment of chronic plaque psoriasis.
Advancements in Understanding the Skin's Microbiomes
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Narrow-Spectrum Antibiotics: The Precision Medicine of Acne?
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
New Advancements in Surgical Scar Revision
New Data Shows Promising Results in Treatment of Hand and Foot Atopic Dermatitis